Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 20-Feb-24 7:31 PM View:  | Kanesa-Thasan Niranjan | Icosavax, Inc. (ICVX) | 19-Feb-24 | Disposition (change in control) | 223,980 | -- | -- | (100%) 223.98K to 0 | |
| 20-Feb-24 7:41 PM View: | Shiver John W. | Icosavax, Inc. (ICVX) | 19-Feb-24 | Disposition | 2,833 | -- | -- | (26%) 10.9K to 8.07K | |
| 20-Feb-24 7:44 PM View: | Wassil Jim | Icosavax, Inc. (ICVX) | 19-Feb-24 | Disposition | 7,392 | -- | -- | (67%) 11.09K to 3.69K | |
| 20-Feb-24 8:07 PM View: | Ra Capital Management, LLC Director 10% Owner | Icosavax, Inc. (ICVX) | 19-Feb-24 | Disposition (change in control) | 5,969,110 | -- | -- | (100%) 5.97M to 0 | |
| 20-Feb-24 7:48 PM View: | Kunz Heidi | Icosavax, Inc. (ICVX) | 19-Feb-24 | Disposition (change in control) | 11,376 | -- | -- | (100%) 11.38K to 0 | |
| 20-Feb-24 7:51 PM View: | Veneman Ann M | Icosavax, Inc. (ICVX) | 19-Feb-24 | Disposition (change in control) | 11,209 | -- | -- | (100%) 11.21K to 0 | |
| 20-Feb-24 7:38 PM View: | McDade Mark | Icosavax, Inc. (ICVX) | 19-Feb-24 | Disposition (change in control) | 55,786 | -- | -- | (2%) 3.57M to 3.51M | |
| 20-Feb-24 7:41 PM View: | Shiver John W. | Icosavax, Inc. (ICVX) | 19-Feb-24 | Disposition (change in control) | 8,066 | -- | -- | (100%) 8.07K to 0 | |
| 20-Feb-24 7:44 PM View: | Wassil Jim | Icosavax, Inc. (ICVX) | 19-Feb-24 | Disposition (change in control) | 3,695 | -- | -- | (100%) 3.69K to 0 | |
| 20-Feb-24 7:50 PM View: | Cearley Cassia | Icosavax, Inc. (ICVX) | 19-Feb-24 | Disposition (change in control) | 131,799 | -- | -- | (100%) 131.8K to 0 | |
| 20-Feb-24 7:58 PM View: | Simpson Adam K. | Icosavax, Inc. (ICVX) | 19-Feb-24 | Disposition (change in control) | 358,657 | -- | -- | (31%) 1.14M to 783.11K | |
| 20-Feb-24 7:38 PM View: | McDade Mark | Icosavax, Inc. (ICVX) | 19-Feb-24 | Disposition (change in control) | 3,510,230 | -- | -- | (100%) 3.51M to 0 | |
| 20-Feb-24 7:43 PM View: | Russo Thomas Joseph | Icosavax, Inc. (ICVX) | 19-Feb-24 | Disposition (change in control) | 39,367 | -- | -- | (100%) 39.37K to 0 | |
| 20-Feb-24 7:48 PM View: | Kunz Heidi | Icosavax, Inc. (ICVX) | 19-Feb-24 | Disposition | 2,917 | -- | -- | (20%) 14.29K to 11.38K | |
| 20-Feb-24 7:51 PM View: | Veneman Ann M | Icosavax, Inc. (ICVX) | 19-Feb-24 | Disposition | 2,834 | -- | -- | (20%) 14.04K to 11.21K | |
| 20-Feb-24 7:58 PM View: | Simpson Adam K. | Icosavax, Inc. (ICVX) | 19-Feb-24 | Disposition (change in control) | 783,108 | -- | -- | (100%) 783.11K to 0 | |
| 02-Feb-24 7:03 PM View: | Simpson Adam K. Chief Executive Officer Director | Icosavax, Inc. (ICVX) | 01-Feb-24 | Gift | 6,532 | -- | -- | (< 1%) 1.03M to 1.03M | |
| 02-Feb-24 7:03 PM View: | Simpson Adam K. Chief Executive Officer Director | Icosavax, Inc. (ICVX) | 01-Feb-24 | Option Exercise | 15,000 | $1.04 | $15,600.00 | 1% 1.02M to 1.03M | |
| 02-Feb-24 7:03 PM View: | Simpson Adam K. Chief Executive Officer Director | Icosavax, Inc. (ICVX) | 01-Feb-24 | Planned Option Sale | 15,000 | $15.29 | $229,386.00 | (1%) 1.03M to 1.01M | |
| 23-Jan-24 6:15 PM View: | Simpson Adam K. Chief Executive Officer Director | Icosavax, Inc. (ICVX) | 22-Jan-24 | Option Exercise | 98,016 | $1.03 | $100,979.00 | 25% 389.67K to 487.69K | |
| 04-Jan-24 5:05 PM View: | Simpson Adam K. Chief Executive Officer Director | Icosavax, Inc. (ICVX) | 02-Jan-24 | Option Exercise | 15,000 | $1.04 | $15,600.00 | 4% 389.67K to 404.67K | |
| 04-Jan-24 5:05 PM View: | Simpson Adam K. Chief Executive Officer Director | Icosavax, Inc. (ICVX) | 02-Jan-24 | Planned Option Sale | 15,000 | $15.67 | $235,088.00 | (4%) 404.67K to 389.67K | |
| 22-Dec-23 6:27 PM View: | Simpson Adam K. Chief Executive Officer Director | Icosavax, Inc. (ICVX) | 21-Dec-23 | Option Sale | 40,000 | $15.43 | $617,060.00 | (8%) 479.67K to 439.67K | |
| 22-Dec-23 6:27 PM View: | Simpson Adam K. Chief Executive Officer Director | Icosavax, Inc. (ICVX) | 21-Dec-23 | Planned Option Sale | 50,000 | $15.44 | $772,220.00 | (11%) 439.67K to 389.67K | |
| 22-Dec-23 6:27 PM View: | Simpson Adam K. Chief Executive Officer Director | Icosavax, Inc. (ICVX) | 21-Dec-23 | Option Exercise | 165,917 | $1.36 | $225,085.00 | 53% 313.76K to 479.67K | |
| 22-Dec-23 6:26 PM View: | Russo Thomas Joseph Chief Financial Officer | Icosavax, Inc. (ICVX) | 20-Dec-23 | Market Sale (Planned) | 10,753 | $15.46 | $166,210.00 | (22%) 48.79K to 38.04K | (22%) |
| 22-Dec-23 6:26 PM View: | Russo Thomas Joseph Chief Financial Officer | Icosavax, Inc. (ICVX) | 20-Dec-23 | Market Sale | 4,430 | $15.47 | $68,510.00 | (8%) 53.22K to 48.79K | (22%) |
| 22-Dec-23 6:24 PM View: | Cearley Cassia Chief Business Officer | Icosavax, Inc. (ICVX) | 20-Dec-23 | Market Sale (Planned) | 7,934 | $15.46 | $122,637.00 | (6%) 138.63K to 130.69K | (22%) |
| 22-Dec-23 6:27 PM View: | Simpson Adam K. Chief Executive Officer Director | Icosavax, Inc. (ICVX) | 20-Dec-23 | Market Option Sale (Planned) | 62,205 | $15.46 | $961,509.00 | (17%) 375.96K to 313.76K | (22%) |
| 22-Dec-23 6:25 PM View: | Kanesa-Thasan Niranjan Chief Medical Officer | Icosavax, Inc. (ICVX) | 20-Dec-23 | Market Sale (Planned) | 11,884 | $15.46 | $183,692.00 | (5%) 235.86K to 223.98K | (22%) |
| 15-Dec-23 7:35 PM View: | Cearley Cassia Chief Business Officer | Icosavax, Inc. (ICVX) | 13-Dec-23 | Market Sale (Planned) | 8,759 | $16.01 | $140,190.00 | (6%) 139.96K to 131.2K | (18%) |
| 01-Aug-23 8:54 PM View: | Simpson Adam K. Chief Executive Officer Director | Icosavax, Inc. (ICVX) | 01-Aug-23 | Option Exercise | 3,000 | $0.84 | $2,520.00 | < 1% 372.96K to 375.96K | |
| 01-Aug-23 8:24 PM View: | Cearley Cassia Chief Business Officer | Icosavax, Inc. (ICVX) | 31-Jul-23 | Sale (Planned) | 1,888 | $8.86 | $16,730.50 | (1%) 141.85K to 139.96K | |
| 01-Aug-23 8:32 PM View: | Kanesa-Thasan Niranjan Chief Medical Officer | Icosavax, Inc. (ICVX) | 31-Jul-23 | Sale (Planned) | 3,323 | $8.86 | $29,446.80 | (1%) 239.19K to 235.86K | |
| 01-Aug-23 8:28 PM View: | Russo Thomas Joseph Chief Financial Officer | Icosavax, Inc. (ICVX) | 31-Jul-23 | Sale (Planned) | 3,066 | $8.86 | $27,169.40 | (6%) 48.69K to 45.62K | |
| 01-Aug-23 8:30 PM View: | Simpson Adam K. Chief Executive Officer Director | Icosavax, Inc. (ICVX) | 31-Jul-23 | Sale (Planned) | 11,788 | $8.86 | $104,459.00 | (3%) 384.75K to 372.96K | |
| 03-Jul-23 7:43 PM View: | Holtzman Douglas Chief Scientific Officer | Icosavax, Inc. (ICVX) | 03-Jul-23 | Option Exercise | 16,356 | $1.04 | $17,010.20 | 6% 292.85K to 309.2K | |
| 03-Jul-23 7:43 PM View: | Holtzman Douglas Chief Scientific Officer | Icosavax, Inc. (ICVX) | 03-Jul-23 | Planned Option Sale | 16,356 | $8.85 | $144,743.00 | (5%) 309.2K to 292.85K | |
| 25-May-23 7:39 PM View: | Cearley Cassia Chief Business Officer | Icosavax, Inc. (ICVX) | 23-May-23 | Sale (Planned) | 10,000 | $10.00 | $100,000.00 | (7%) 151.85K to 141.85K | |
| 05-Apr-23 7:12 PM View: | Holtzman Douglas Chief Scientific Officer | Icosavax, Inc. (ICVX) | 03-Apr-23 | Planned Option Sale | 20,443 | $6.09 | $124,407.00 | (7%) 313.29K to 292.85K | |
| 05-Apr-23 7:12 PM View: | Holtzman Douglas Chief Scientific Officer | Icosavax, Inc. (ICVX) | 03-Apr-23 | Option Exercise | 20,443 | $1.04 | $21,260.70 | 7% 292.85K to 313.29K | |
| 08-Mar-23 5:45 PM View: | Cearley Cassia Chief Business Officer | Icosavax, Inc. (ICVX) | 06-Mar-23 | Sale (Planned) | 5,000 | $7.75 | $38,737.00 | (3%) 156.85K to 151.85K | |
| 16-Feb-23 8:00 PM View: | Simpson Adam K. Chief Executive Officer Director | Icosavax, Inc. (ICVX) | 15-Feb-23 | Option Exercise | 10,677 | $1.04 | $11,104.10 | 3% 374.07K to 384.75K | |
| 15-Feb-23 8:07 PM View: | Holtzman Douglas Chief Scientific Officer | Icosavax, Inc. (ICVX) | 14-Feb-23 | Sale (Planned) | 3,349 | $10.17 | $34,064.40 | (1%) 296.19K to 292.85K | |
| 15-Feb-23 8:12 PM View: | Bekiroglu Elizabeth General Counsel & Corp. Sec. | Icosavax, Inc. (ICVX) | 13-Feb-23 | Sale (Planned) | 5,922 | $10.69 | $63,321.60 | (5%) 108.93K to 103.01K | |
| 15-Feb-23 8:07 PM View: | Holtzman Douglas Chief Scientific Officer | Icosavax, Inc. (ICVX) | 13-Feb-23 | Sale (Planned) | 1,522 | $10.69 | $16,274.10 | (< 1%) 297.72K to 296.19K | |
| 15-Feb-23 8:09 PM View: | Simpson Adam K. Chief Executive Officer Director | Icosavax, Inc. (ICVX) | 13-Feb-23 | Sale (Planned) | 7,506 | $10.69 | $80,258.70 | (2%) 381.58K to 374.07K | |
| 15-Feb-23 7:58 PM View: | Kanesa-Thasan Niranjan Chief Medical Officer | Icosavax, Inc. (ICVX) | 13-Feb-23 | Sale (Planned) | 1,794 | $10.69 | $19,182.50 | (< 1%) 240.98K to 239.19K | |
| 15-Feb-23 7:56 PM View: | Cearley Cassia Chief Business Officer | Icosavax, Inc. (ICVX) | 13-Feb-23 | Sale (Planned) | 1,660 | $10.69 | $17,749.70 | (1%) 158.51K to 156.85K | |
| 15-Feb-23 8:04 PM View: | Russo Thomas Joseph Chief Financial Officer | Icosavax, Inc. (ICVX) | 13-Feb-23 | Sale (Planned) | 1,902 | $10.69 | $20,337.30 | (4%) 50.59K to 48.69K |
